205 related articles for article (PubMed ID: 30445957)
21. High Prevalence of Antibodies against Canine Parvovirus and Canine Distemper Virus among Coyotes and Foxes from Pennsylvania: Implications for the Intersection of Companion Animals and Wildlife.
Kimpston CN; Hatke AL; Castelli B; Otto N; Tiffin HS; Machtinger ET; Brown JD; Van Why KR; Marconi RT
Microbiol Spectr; 2022 Feb; 10(1):e0253221. PubMed ID: 35080421
[No Abstract] [Full Text] [Related]
22. A point-of-care dot blot ELISA assay for detection of protective antibody against canine adenovirus, canine parvovirus, and canine distemper virus is diagnostically accurate.
Egerer A; Schaefer Z; Larson L
J Am Vet Med Assoc; 2022 Oct; 260(15):1928-1933. PubMed ID: 36198054
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Immunity and Seropositivity of IgG Antibodies to Canine Parvoviruses in Vaccinated and Unvaccinated Dogs in Abeokuta, Nigeria.
Babalola ET; Ijaopo OK; Okonko IO
J Immunoassay Immunochem; 2016; 37(1):16-28. PubMed ID: 25891124
[TBL] [Abstract][Full Text] [Related]
24. Thoughts on vaccination protocols.
Petzel B
J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
[No Abstract] [Full Text] [Related]
25. Clinical assessment of a point-of-care assay to determine protective vaccinal antibody titers to canine viral diseases.
Ad Y; Halperin IM; Olstad EC; Gershwin LJ; Sullivan L; Reagan KL
Vet J; 2023; 298-299():106017. PubMed ID: 37524148
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
[TBL] [Abstract][Full Text] [Related]
27. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
Coyne MJ
J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
[TBL] [Abstract][Full Text] [Related]
28. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
[TBL] [Abstract][Full Text] [Related]
29. Association between cancer chemotherapy and canine distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs.
Henry CJ; McCaw DL; Brock KV; Stoker AM; Tyler JW; Tate DJ; Higginbotham ML
J Am Vet Med Assoc; 2001 Nov; 219(9):1238-41. PubMed ID: 11697366
[TBL] [Abstract][Full Text] [Related]
30. Thoughts on vaccination protocols.
McLaughlin MA
J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
[No Abstract] [Full Text] [Related]
31. Duration of immunity in red wolves (Canis rufus) following vaccination with a modified live parvovirus and canine distemper vaccine.
Anderson K; Case A; Woodie K; Waddell W; Reed HH
J Zoo Wildl Med; 2014 Sep; 45(3):550-4. PubMed ID: 25314821
[TBL] [Abstract][Full Text] [Related]
32. Serological responses of adult dogs to revaccination against distemper, parvovirus and rabies.
Ottiger HP; Neimeier-Förster M; Stärk KD; Duchow K; Bruckner L
Vet Rec; 2006 Jul; 159(1):7-12. PubMed ID: 16816154
[TBL] [Abstract][Full Text] [Related]
33. CANINE DISTEMPER AND PARVOVIRUS VACCINATION WITH RECOMBITEK C3 IN AFRICAN WILD DOGS (
Mulreany LM; Cushing AC; Ramsay EC
J Zoo Wildl Med; 2021 Dec; 52(4):1229-1233. PubMed ID: 34998293
[TBL] [Abstract][Full Text] [Related]
34. Antibody titers for canine parvovirus type-2, canine distemper virus, and canine adenovirus type-1 in adult household dogs.
Taguchi M; Namikawa K; Maruo T; Orito K; Lynch J; Sahara H
Can Vet J; 2011 Sep; 52(9):983-6. PubMed ID: 22379198
[TBL] [Abstract][Full Text] [Related]
35. Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs.
Twark L; Dodds WJ
J Am Vet Med Assoc; 2000 Oct; 217(7):1021-4. PubMed ID: 11019708
[TBL] [Abstract][Full Text] [Related]
36. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
Larson LJ; Schultz RD
Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
[TBL] [Abstract][Full Text] [Related]
37. Canine viral vaccines at a turning point--a personal perspective.
Carmichael LE
Adv Vet Med; 1999; 41():289-307. PubMed ID: 9890023
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of antibodies against canine distemper virus and canine parvovirus among foxes and wolves from Spain.
Sobrino R; Arnal MC; Luco DF; Gortázar C
Vet Microbiol; 2008 Jan; 126(1-3):251-6. PubMed ID: 17646060
[TBL] [Abstract][Full Text] [Related]
39. [Effect of maternally derived antibody levels on antibody responses to canine parvovirus, canine distemper virus and infectious canine hepatitis virus after vaccinations in beagle puppies].
Iida H; Fukuda S; Kawashima N; Yamazaki T; Aoki J; Tokita K; Morioka K; Takarada N; Soeda T
Jikken Dobutsu; 1990 Jan; 39(1):9-19. PubMed ID: 2303100
[TBL] [Abstract][Full Text] [Related]
40. Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs.
Touihri L; Ahmed SB; Chtourou Y; Daoud R; Bahloul C
Virol J; 2012 Dec; 9():319. PubMed ID: 23270301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
